126689-77-8

Basic information

• Product Name: methyl 2-[(3-methoxyphenyl)amino]acetate
• Synonyms: methyl 2-[(3-methoxyphenyl)amino]acetate
• CAS NO: 126689-77-8
• Molecular Formula: C10H13NO3
• Molecular Weight: 195.21512
• Mol File: 126689-77-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: methyl 2-[(3-methoxyphenyl)amino]acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-[(3-methoxyphenyl)amino]acetate(126689-77-8)
• EPA Substance Registry System: methyl 2-[(3-methoxyphenyl)amino]acetate(126689-77-8)

Safety Data

• Hazardous Substances Data: 126689-77-8(Hazardous Substances Data)

Upstream product

• 85676-52-4 DL-m-methoxyphenylglycine 
• 536-90-3 m-Anisidine 
• 96-32-2 bromoacetic acid methyl ester 

Downstream Products

• 1476035-28-5 (Z)-methyl 2-[(3-methoxyphenyl)amino]-3-(dimethylamino)acrylate 
• 98081-83-5 methyl 6-methoxy-1H-indole-2-carboxylate 

Relevant articles and documents

Iodine-mediated one-pot synthesis of indoles and 3-dimethylaminoindoles via annulation of enaminones

The synthesis of 2-carbonylindoles was achieved via a iodine-mediated cyclization of the corresponding enaminone precursors, which were formed by reaction of the ?-arylaminomethylene carbonyl derivatives with N,N'-dimethylformamide dimethyl acetal (DMFDMA). An alternative and more efficient procedure consisted of a similar cyclization of the enaminones, but under solvent-free and grinding reaction conditions. In another iodine-promoted procedure, 2-carbonyl-3-dimethylaminoindoles were synthesized via a one-pot cascade reaction between the α-arylaminomethylene carbonyl derivative and DMFDMA.ARKAT-USA, Inc.

Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers

We have synthesized and biologically evaluated 1,4-diazepane derivatives as T-type calcium channel blockers. In this study, we discovered compound 4s, a potential T-type calcium channel blocker with good selectivity over hERG and N-type calcium channels. In addition, it exhibited favorable pharmacokinetic characteristics for further investigation of T-type calcium channel related diseases.

Production of an ester of one enantiomer of an α-amino acid in the form of a salt with an optically active acid

A process for the production of an ester of one enantiomer of an α-amino acid in the form of a salt with an optically active acid, which comprises reacting an ester of the opposite enantiomer of said α-amino acid (which may be in admixture with an ester of the desired enantiomer) with said optically active acid and an aldehyde or ketone, whereby an ester of the desired enantiomer separates out in the form of the said salt. The free α-amino acid and/or its salts may be obtained by hydrolysis of the ester thus formed. Optically active α-amino acids and their esters are of use in the synthesis of physiologically active compounds e.g. antibiotics of the penicillin and cephalosporin types. The present invention provides a relatively cheap, high yield process for the production of esters of optically active α-amino acids and for the production of optically active α-amino acids thereform. Certain novel compounds are disclosed.